Danaher Corporation (DHR) Shares Bought by Sunbelt Securities Inc.
Sunbelt Securities Inc. grew its position in shares of Danaher Corporation (NYSE:DHR) by 8.2% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,688 shares of the conglomerate’s stock after buying an additional 279 shares during the period. Sunbelt Securities Inc.’s holdings in Danaher Corporation were worth $311,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. ETRADE Capital Management LLC raised its position in shares of Danaher Corporation by 5.1% during the 2nd quarter. ETRADE Capital Management LLC now owns 19,075 shares of the conglomerate’s stock worth $1,610,000 after purchasing an additional 917 shares during the period. Honeywell International Inc. acquired a new stake in shares of Danaher Corporation during the 2nd quarter worth approximately $25,317,000. Roundview Capital LLC raised its position in shares of Danaher Corporation by 2.0% during the 2nd quarter. Roundview Capital LLC now owns 25,674 shares of the conglomerate’s stock worth $2,167,000 after purchasing an additional 502 shares during the period. Israel Discount Bank of New York acquired a new stake in shares of Danaher Corporation during the 1st quarter worth approximately $209,000. Finally, Eastern Bank raised its position in shares of Danaher Corporation by 4,291.1% during the 2nd quarter. Eastern Bank now owns 128,001 shares of the conglomerate’s stock worth $10,802,000 after purchasing an additional 125,086 shares during the period. 75.49% of the stock is currently owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: “Danaher Corporation (DHR) Shares Bought by Sunbelt Securities Inc.” was originally published by Watch List News and is owned by of Watch List News. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.watchlistnews.com/danaher-corporation-dhr-shares-bought-by-sunbelt-securities-inc/1680142.html.
In other news, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the firm’s stock in a transaction on Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total transaction of $11,671,620.96. Following the completion of the sale, the chief executive officer now directly owns 271,737 shares of the company’s stock, valued at approximately $25,173,715.68. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Donald J. Ehrlich sold 10,578 shares of the firm’s stock in a transaction on Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total value of $960,693.96. Following the sale, the director now directly owns 104,621 shares of the company’s stock, valued at $9,501,679.22. The disclosure for this sale can be found here. Over the last three months, insiders have sold 279,628 shares of company stock valued at $25,304,394. Corporate insiders own 12.20% of the company’s stock.
Danaher Corporation (DHR) opened at $93.13 on Friday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. The stock has a market capitalization of $64,778.21, a price-to-earnings ratio of 23.94, a price-to-earnings-growth ratio of 2.21 and a beta of 1.02. Danaher Corporation has a one year low of $76.27 and a one year high of $93.16.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.05. The business had revenue of $4.53 billion during the quarter, compared to analyst estimates of $4.47 billion. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The company’s revenue was up 9.6% compared to the same quarter last year. During the same period last year, the company posted $0.87 EPS. equities research analysts predict that Danaher Corporation will post 3.99 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, September 29th were paid a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.60%. The ex-dividend date was Thursday, September 28th. Danaher Corporation’s dividend payout ratio is presently 16.52%.
A number of brokerages have recently weighed in on DHR. Wells Fargo & Company reiterated a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Cowen and Company reiterated a “buy” rating and set a $90.00 price target on shares of Danaher Corporation in a research report on Wednesday, October 4th. Jefferies Group LLC reiterated a “buy” rating and set a $95.00 price target on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub cut Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Finally, Morgan Stanley restated an “overweight” rating and issued a $95.00 target price (up from $86.00) on shares of Danaher Corporation in a research report on Friday, October 6th. One research analyst has rated the stock with a sell rating, four have given a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $93.31.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.